Day: March 11, 2022

ST. PETERSBURG, Fla., March 11, 2022 (GLOBE NEWSWIRE) — Global Technologies, Ltd (OTC Pink: GTLL) (the “Company”), a holding corporation, which, through its subsidiaries, has operations engaged in the online sales of CBD and hemp-related products, the acquisition of intellectual property in the safety and security space, and as a portal for entrepreneurs to provide immediate access to live shopping, e-commerce, distribution and logistics, is pleased to inform shareholders that it has entered into a Definitive Share Exchange Agreement with Tersus Power, Inc. (“Tersus Power”). Terms As previously announced on November 17, 2021, the Company entered into a Letter of Intent to acquire Tersus Power. On March 9, 2022, the Company entered into a Share Exchange Agreement (the “Exchange Agreement”) with Tersus Power and the Tersus Shareholders....

TORONTO, March 11, 2022 (GLOBE NEWSWIRE) — VitalHub Corp. (the “Company” or “VitalHub”) (TSX: VHI) is pleased to announce a multi-year licensing deal of subsidiary Intouch with Health’s (“Intouch”) software solutions with Bedfordshire Hospitals NHS Foundation Trust (the “Trust” or “Bedfordshire Hospitals”). This transaction comprises the 7th Intouch with Health deal announced this quarter. Bedfordshire Hospitals NHS Trust is a new customer of the Company, with the Trust engaging with Intouch last year to look at improving efficiencies in assisting with the management of their elective care backlog. Bedfordshire Hospitals NHS Foundation Trust is a large general hospital across two sites, Luton & Dunstable University Hospital and Bedford Hospital. The Trust provides a comprehensive range of general medical and surgical services,...

Paul C. Harris Paul C. HarrisNEWPORT NEWS, Va., March 11, 2022 (GLOBE NEWSWIRE) — Global engineering and defense technologies provider HII (NYSE:HII) announced today that Paul C. Harris has been appointed executive vice president and chief sustainability and compliance officer, reporting directly to HII President and CEO Chris Kastner on matters of sustainability. The move expands the scope of responsibilities for Harris, who has served as HII’s chief compliance officer since 2020. In his new role he will oversee the company’s ongoing efforts to formalize and mature its strategy-driven environmental, social and governance program, in addition to overseeing matters of compliance. “Paul has demonstrated true leadership in enhancing our culture of ethics and compliance at HII,” Kastner said. “We see sustainability as important...

SAN DIEGO, March 11, 2022 (GLOBE NEWSWIRE) — TRACON Pharmaceuticals (NASDAQ: TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted cancer therapeutics and utilizing a cost efficient, CRO-independent product development platform to partner with ex-U.S. companies to develop and commercialize innovative products in the U.S., today announced that Charles Theuer, M.D., Ph.D., President and Chief Executive Officer, will present a corporate overview at the Oppenheimer 32nd Annual Healthcare Conference on Wednesday, March 16, 2022 at 4:00pm Eastern Time. To access a live webcast or replay of the presentation, please visit the “Events and Presentations” page within the “Investors” section of the TRACON Pharmaceuticals website at www.traconpharma.com. About TRACON TRACON develops...

CORAL GABLES, Fla., March 11, 2022 (GLOBE NEWSWIRE) — Catalyst Pharmaceuticals, Inc. (“Catalyst”) (Nasdaq: CPRX), a commercial-stage, patient-centric biopharmaceutical company focused on in-licensing, developing, and commercializing novel high-quality medicines for patients living with rare diseases and KYE Pharmaceuticals Inc. (“KYE”), a private company focused on bringing medications that fulfill clinically significant and unmet needs to the Canadian market, today announced receipt of a favorable decision from the Federal Court of Canada (“Court”) setting aside for the second time the decision of Canada’s national healthcare regulatory agency, Health Canada, to approve Ruzurgi® (amifampridine) for Lambert-Eaton Myasthenic Syndrome (“LEMS”) patients. This decision sets aside the Notice of Compliance...

Boston, MA, March 11, 2022 (GLOBE NEWSWIRE) — The U.S. Court of Appeals for the Federal Circuit has affirmed the District Court judgement from April 30, 2021 that the claims of Worlds Inc. (OTCQB: WDDD) asserted patents are invalid under 35 U.S.C. Section 101 (§ 101) as directed to ineligible subject matter. Worlds had asked this Court to reverse an adverse District Court judgment from April 30, 2021 that favored defendants Activision Blizzard Inc., Blizzard Entertainment, Inc., and Activision Publishing, Inc. “We are obviously disappointed in the court’s decision, which issued almost 10 years to the day that Worlds filed its lawsuit against Activision,” Worlds CEO Thom Kidrin stated. “When Worlds filed its lawsuit against the Activision entities in 2012, challenges under § 101 were rare. In the last seven years, following the...

PRINCETON, N.J., March 11, 2022 (GLOBE NEWSWIRE) — Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced that Chairman and Chief Executive Officer Al Altomari will participate in two upcoming investor conferences, including a live panel discussion on drug development in Women’s Health.Oppenheimer’s 32nd Annual Virtual Healthcare ConferenceFireside ChatThursday, March 17, 2022 at 2:00 p.m. ETMaxim Group and M-Vest 2022 Virtual Growth ConferenceAdvances in Women’s Health, from Clinical to Commercial Live Panel DiscussionMonday, March 28, 2022 at 3:00 p.m. ETLinks and webcast information for each conference can be found on the Investors section of the Agile Therapeutics website at https://ir.agiletherapeutics.com/events-and-presentations. Each archived webcast will be available...